2023
Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD
Kovacevich A, Weleff J, Claytor B, Barnett B. Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD. Journal Of Psychoactive Drugs 2023, 55: 672-679. PMID: 37650700, DOI: 10.1080/02791072.2023.2253538.Peer-Reviewed Original ResearchConceptsLysergic acid diethylamidePsychedelic useOlfactory impairmentOlfactory improvementClassic psychedelic useCOVID-19-related anosmiaSerotonergic effectsIncreased neuroplasticityAnti-inflammatory effectsNaturalistic useAcid diethylamideOlfactory dysfunctionMicrosmiaPsilocybinRespiratory infectionsPsilocybin mushroomsTherapeutic benefitAnosmiaNovel treatmentReport improvementImpairmentPotential mechanismsBiological plausibilityGrowing bodyWomen
2022
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies
Weleff J, Akiki T, Barnett B. Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies. Journal Of Psychoactive Drugs 2022, 55: 434-444. PMID: 36218281, DOI: 10.1080/02791072.2022.2133757.Peer-Reviewed Original ResearchLysergic acid diethylamidePsychedelic researchBibliometric analysisEffects of psychedelicsStudies of psychedelicsClinical psychedelic researchNon-research settingsPsychiatric treatmentN-dimethyltryptamineProportion of studiesAcid diethylamidePsilocybinPsychedelicsSubanalysis of studiesPsilocybin studiesDimethyltryptamineMDMARelevant articlesMescalinePsychedelics in the Treatment of Substance Use Disorders
Barnett B, Weleff J. Psychedelics in the Treatment of Substance Use Disorders. Psychiatric Annals 2022, 52: 365-370. DOI: 10.3928/00485713-20220804-01.Peer-Reviewed Original ResearchSubstance use disordersPsychedelic experienceTreatment of substance use disordersLysergic acid diethylamideSubjective effectsUse disorderAcid diethylamidePlacebo-controlled trialPsychedelicsBehavioral changesTherapeutic potentialClinician concernsLife narrativesDisordersFacilitation programTreatment paradigmTherapeutic efficacyClinical trialsTreatment potentialObservational studyPsilocybinDiethylamideTrialsSubstancesOpioid